Cost profiles of colorectal cancer patients in Italy based on individual patterns of care

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Francisci, Silvia ^a   Guzzinati, Stefano ^b   Mezzetti, Maura ^c   Crocetti, Emanuele ^d   Giusti, Francesco ^d   Miccinesi, Guido ^d   Paci, Eugenio ^d   Angiolini, Catia ^e   Gigli, Anna ^f  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d Registro Tumori della Regione Toscana ISPO   (Italy)

^e ASF   (Italy)

^f Istituto Di Ricerche Sulla Popolazione E Le Politiche Sociali Rome   (Italy)

Author keywords

Administrative data; Cancer registry; Care pathway; Direct costs; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVOR; COLORECTAL CANCER; FEMALE; HEALTH CARE COST; HOSPITAL DISCHARGE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PATIENT CARE; PREVALENCE; COLORECTAL NEOPLASMS; ECONOMICS; MIDDLE AGED; REGISTER; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; ITALY; MALE; MIDDLE AGED; REGISTRIES; YOUNG ADULT;

EID: 84875477025     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-329     Document Type: Article

References (43)

1. Sullivan S, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, Khayat D, Boyle P, Autier P, Tannock IF, Fojo T, Siderov J, Williamson S, Camporesi S, McVie JG, Purushotham AD, Naredi P, Eggermont A, Brennan MF, Steinberg ML, De Ridder M, McCloskey SA, Verellen D, Roberts T, Storme G, Hicks RJ, Ell PJ, Hirsch BR, Carbone DP, Schulman KA, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol 2011, 12:933-980. 10.1016/S1470-2045(11)70141-3, 21958503.
2. Buzzoni C and the AIRTUM Working group Population aging effect on number of cancer cases: Italian cancer registries data. Epidemiol Prev 2011, 35:216-221. Buzzoni C and the AIRTUM Working group.
3. Simoens S, Dooms M. How much is the life of a cancer patient worth? A pharmaco-economic perspective. J Clin Pharm and Therap 2011, 36:249-256.
4. Meropol NJ, Schulman KA. Cost of cancer care: issues and implications. J Clin Oncol 2007, 25:180-186. 10.1200/JCO.2006.09.6081, 17210937.
5. Brown ML, Fireman B. Evaluation of direct medical costs related to cancer. J Natl Cancer Inst 1995, 87:399-400. 10.1093/jnci/87.6.399, 7861454.
6. Barlow WE. Overview of methods to estimate the medical costs of cancer. Med Care 2009, 47(Suppl 1):33-36.
7. Yabroff RK, Mariotto AB, Feuer EJ, Brown ML. Projections of the costs associated with colorectal cancer care in the United States, 2000-2020. Health Econ 2008, 17:947-959. 10.1002/hec.1307, 17910108.
8. Mariotto A, Yabroff RK, Feuer EJ, De Angelis R, Brown M. Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020. Cancer Causes Control 2006, 17:1215-1226. 10.1007/s10552-006-0072-0, 17111252.
9. Maher J, McConnell H. New pathways of care for cancer survivors: adding the numbers. Br J Cancer 2011, 105(Suppl 1):5-10.
10. Brown ML, Riley GF, Schussler M, Etzioni R. Estimating health care costs related to cancer treatment from SEER-medicare data. Med Care 2002, 40:IV 104-IV 117.
11. AIRTUM Working Group La prevalenza dei tumori in Italia. Epidemiol Prev 2010, 34(Suppl 2):1-54. AIRTUM Working Group.
12. National Institute for Statistics (Istat) Noi Italia, 100 statistiche per capire il paese in cui viviamo: sanità e salute 2011, Roma: Dossier Istat, National Institute for Statistics (Istat).
13. Russo A, Bisanti L. Milan Cancer Report 2007, Milano: ASL Città di Milano.
14. Castiglione G, Zappa M, Grazzini G, Sani C, Mazzotta A, Mantellini P, Ciatto S. Cost analysis in a population based screening programme for colorectal cancer: comparison of immunochemical and guaiac faecal occult blood testing. J Med Screen 1997, 4:142-146.
15. Zappa M, Cecchini S, Ciatto S, Iossa A, Falini P, Mancini M, Paci E. Measurement of the cost of screening for cervical cancer in the district of Florence, Italy. Tumori 1998, 84:631-635.
16. Zappa M, Visioli CB, Ciatto S. Mammography screening in elderly women: efficacy and cost-effectiveness. Crit Rev Oncol Hematol 2003, 46:235-239. 10.1016/S1040-8428(03)00022-2, 12791422.
17. Carozzi FM, Cariaggi MP, Bonardi L, Bulgaresi P, Cecchini S, Ciatto S, Cipparrone I, Galanti L, Maddau C, Matucci M, Rubeca T, Troni GM, Turco P, Zappa M, Confortini M. Clinical impact (cost-effectiveness) of qualifying atypical squamous cells of undeterminate significance (ASCUS) in cases favoring a reactive or dysplastic process. Diagn Cytopathol 2003, 29:4-7. 10.1002/dc.10317, 12827706.
18. Grazzini G, Ciatto S, Cislaghi C, Castiglione G, Falcone M, Mantellini P, Zappa M. and the Working Group of Regional Reference Centre for Oncological Screening of Tuscany Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence. J Med Screen 2008, 15:175-181. 10.1258/jms.2008.008032, 19106257, and the Working Group of Regional Reference Centre for Oncological Screening of Tuscany.
19. Accetta G, Biggeri A, Carreras G, Lippi G, Carozzi FM, Confortini M, Zappa M, Paci E. Is human papilloma virus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis. J Med Screen 2010, 17:181-189. 10.1258/jms.2010.010019, 21258128.
20. Associazione italiana dei registri tumori (AIRTUM) [http://www.registri-tumori.it].
21. Zambon P, Andolfo A, Baracco M, Barizza F, Bovo E, Dal Cin A, Fiore AR, Greco A, Guzzinati S, Monetti D, Rosano D, Stocco CF, Tognazzo S. Cancer incidence in Italy, Veneto region (1998-2001). Cancer Incidence in Five Continents. vol IX 2007, Lyon: IARC, Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P.
22. Paci E, Crocetti E, Benvenuti A, Buzzoni C, Caldarella A, Giovannetti L, Giusti F, Intrieri T, Manneschi G, Miccinesi G, Sacchettini C. Tuscany cancer registry. Cancer Incidence in Five Continents. vol IX 2007, Lyon: IARC, Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P.
23. Gail MH, Kessler L, Midthune D, Scoppa S. Two approaches for estimating disease prevalence from population-based registries of incidence and total mortality. Biometrics 1999, 55:1137-1144. 10.1111/j.0006-341X.1999.01137.x, 11315059.
24. Gigli A, Mariotto A, Clegg LX, et al. Estimating the variance of cancer prevalence from population-based registries. Stat Methods Med Res 2006, 15:235-253. 10.1191/0962280206sm427oa, 16768298.
25. Italian Ministerial Decree DRG (Diagnosis-related Groups) version 10 1994, Rome: Presidenza del Consiglio dei Ministri, Italian Ministerial Decree.
26. World Health Organization International classification of diseases 9th revision, clinical modification 1997, Geneva: World Health Organization, World Health Organization.
27. American Joint Committee on Cancer Colon and rectum. AJCC Cancer Staging Manual 2010, 143-164. New York: Springer-Verlag, Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, American Joint Committee on Cancer.
28. Corazziari I, Quinn M, Capocaccia R. Standard cancer population for estimating age standardized survival ratios. Eur J Cancer 2004, 40:2307-2316. 10.1016/j.ejca.2004.07.002, 15454257.
29. SEER*Stat Software Latest Release: Version 7.0.5 [http://seer.cancer.gov/seerstat/].
30. Francisci S, Capocaccia R, Grande E, Santaquilani M, Simonetti A, Allemani C, Gatta G, Sant M, Zigon G, Bray F, Janssen-Heijnen M. and the EUROCARE Working Group The cure of cancer: a European perspective. Eur J Cancer 2009, 45:1067-1079. 10.1016/j.ejca.2008.11.034, 19131242, and the EUROCARE Working Group.
31. Brown ML, Riley GF, Potosky AL, Etzioni RD. Obtaining long-term disease specifi c costs of care: application to medicare enrollees diagnosed with colorectal cancer. Med Care 1999, 37:1249-1259. 10.1097/00005650-199912000-00008, 10599606.
32. Meropol NJ. Ongoing challenge of stage II colon cancer. J Clin Oncol 2011, 29:3346-3348. 10.1200/JCO.2011.35.4571, 21788557.
33. O' Connor ES, Greenblatt DY, LoConte NK, Gangnon RE, Liou J, Heise CP, Smith MA. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol 2011, 29:3381-3388. 10.1200/JCO.2010.34.3426, 3164243, 21788561.
34. Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, de Braud F, Wils J. Colon cancer. European options and recommendations for cancer diagnosis and therapy. Volume 1 2011, Brussels: Organisation of European Cancer Institutes, OECHEEIG, Pierotti MA, van Harten W, Licitra L, Lombardo C.
35. Zampino MG, Labianca R, Beretta GD, Magni E, Gatta G, Leonardi MC, Chiappa A, Biffi R, de Braud F, Wils J. Rectal cancer. European options and recommendations for cancer diagnosis and therapy. Volume 1 2011, Brussels: Organisation of European Cancer Institutes, OECHEEIG, Pierotti MA, van Harten W, Licitra L, Lombardo C.
36. Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labianca R, Haller DG, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001, 345:1091-1097. 10.1056/NEJMoa010957, 11596588.
37. Yabroff RK, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, Brown ML. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst 2008, 100:630-634. 10.1093/jnci/djn103, 18445825.
38. Warren JL, Yabroff K, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst 2008, 100:888-897. 10.1093/jnci/djn175, 3298963, 18544740.
39. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for jointpoint regression with application to cancer rates. Stat Med 2000, 19:335-351. 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z, 10649300.
40. Giunta Regionale del Veneto Relazione Socio sanitaria della regione del Veneto (dati 2006-2007) 2008, Venezia: Regione Veneto, Giunta Regionale del Veneto.
41. Bollettino ufficiale della Regione Toscana Piano sanitario regionale 2008-2010 2008, Firenze: Regione Toscana, Bollettino ufficiale della Regione Toscana.
42. Complete Prevalence (ComPrev) Software Version 2.0 [http://surveillance.cancer.gov/comprev/].
43. Fetter RB, Thompson JD, Mills RE. System for a cost and reimbursement control in hospital. Yale J Biol Med 1976, 9:123-136.